Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹53 Cr
Revenue (TTM)
₹54 Cr
Net Profit (TTM)
₹-3 Cr
ROE
-25.2 %
ROCE
-8.2 %
P/E Ratio
--
P/B Ratio
1.7
Industry P/E
--
EV/EBITDA
29.9
Div. Yield
0 %
Debt to Equity
1.1
Book Value
₹27.9
EPS
₹-2.6
Face value
10
Shares outstanding
10,922,432
CFO
₹6.87 Cr
EBITDA
₹37.90 Cr
Net Profit
₹12.25 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Banka Bioloo
| -27.2 | -18.6 | -27.4 | -43.3 | -12.0 | -4.5 | -- |
|
BSE CG
| 1.5 | -1.8 | 1.2 | 10.8 | 24.9 | 26.1 | 18.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Banka Bioloo
| -33.3 | -13.6 | 41.0 | -0.4 | 38.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE CG
| -1.0 | 21.6 | 66.9 | 16.0 | 53.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Banka Bioloo
|
48.7 | 53.2 | 54.3 | -2.9 | -2.1 | -9.2 | -- | 1.7 |
| 241.6 | 646.1 | 249.2 | 65.5 | 31.9 | 15.5 | 9.9 | 1.4 | |
| 204.8 | 473.9 | 185.1 | 20.1 | -- | 30.4 | 23.6 | 5.0 | |
| 147.9 | 2,595.2 | 1,111.2 | 208.2 | 25.0 | 19.7 | 12.7 | 2.2 | |
| 71.0 | 42.1 | 38.9 | 4.7 | -- | 46.7 | 9 | 1.4 | |
| 81.8 | 14,140.4 | 4,427.7 | 535.0 | 16.9 | 8.6 | 27.9 | 2.1 | |
| 41.5 | 25,067.9 | 7,870.4 | 768.8 | 35.4 | 4 | 32.6 | 1.2 | |
| 1,071.0 | 18,312.8 | 26,431.9 | 818.2 | 6.1 | 12.6 | 22 | 2.6 | |
| 83.9 | 22,655.7 | 12,966.3 | 671.9 | 4.6 | 25.8 | 34.6 | 7.9 | |
| 46.9 | 81.9 | 93.7 | 9.1 | -- | 27.1 | 9 | 1.0 |
No Review & Analysis are available.
Banka BioLoo Limited engages in the sanitation, fecal sludge, and wastewater treatment businesses in India. It is involved in the operation, setting up, and maintenance of fecal sludge, waste water, and effluent treatment plants. The company offers... BioToilet, BioDigester, and FootLoo; packaged sewage treatment plant; and urban sewage treatment plant. It is also involved in the installation and maintenance of bio toilets for Indian railways. In addition, the company produces granules and biopelettes for compostible packaging. It provides its solutions for communities, industrials, retail, and commercial sectors. The company was incorporated in 2012 and is based in Hyderabad, India. Read more
Incorporated
2012
Chairman
Sanjay Banka
Managing Director
Namita Banka
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Banka Bioloo Ltd.’s IPO? Explore our IPO Details page.
Announcements
View AnnouncementsResignation of Independent director
01-Feb-2024Resignation of Independent director
31-Jan-2024The share price of Banka Bioloo Ltd is ₹48.73 (NSE) as of 20-Mar-2026 IST. Banka Bioloo Ltd has given a return of -11.96% in the last 3 years.
Since, TTM earnings of Banka Bioloo Ltd is negative, P/E ratio is not available.
The P/B ratio of Banka Bioloo Ltd is 1.74 times as on 20-Mar-2026, a 0 premium to its peers’ median range of 1.74 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
2.54
|
|
2024
|
0.00
|
2.56
|
|
2023
|
29.78
|
1.89
|
|
2022
|
28.50
|
2.36
|
|
2021
|
27.86
|
2.05
|
The 52-week high and low of Banka Bioloo Ltd are Rs 97.88 and Rs 45.55 as of 21-Mar-2026.
Banka Bioloo Ltd has a market capitalisation of ₹ 53 Cr as on 20-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Banka Bioloo Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.